ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Growth

Regular

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.
Direct

Regular and Direct options of the funds are exactly same except commission to your mutual fund broker/distributor. As an investor you do not need to pay any additional fees to purchase any of these options. However both have different expense ratios. Regular funds have higher expense ratio and direct funds have lower expense ratio. This difference is because of commission paid to broker/distributor. Lower expense ratio leads to higher returns for investors.

Category : Sectoral/Thematic

Fund House : ICICI Prudential Mutual Fund

NAV

This number shows latest NAV (Net Asset Value) and change in the NAV from previous day. NAV is nothing but the unit price for the fund. You will be allocated number of units based on this price. NAV is declared once each day generally at the end of the day. Once you invest in mutual funds, your money is further invested in stocks and bonds by mutual fund managers. Mutual Fund NAV is the per unit latest value of all such stocks/bonds held in the portfolio

: ₹ 43.62 -0.37%
(as on 23rd September, 2025)

Crisil Rating

Not Rated

Rank not available for the fund

Fund Size

: ₹ 6161.81 Cr

(1.22% of Investment in Category)

Expense Ratio

: 1.04%

(0.89% Category average)

Risk-O-Meter

Very High Risk

Sectoral/Thematic :Sectoral/Thematic : The fund has 95.88% investment in domestic equities of which 40.3% is in Large Cap stocks, 16.51% is in Mid Cap stocks, 8.84% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

1M
3M
6M
1Y
2Y
5Y
ALL

This Scheme

VS

Benchmark
BSE Healthcare TRI

0%

0%

0%

0%

0%

0%

0%
NA
1.74%

3.91%

12.42%

-1.57%

20.97%

24.54%

14.32%

NA
Gold

Compare with

Date : -
NAV : -

1M
3M
6M
9M
1Y
2Y
3Y
5Y
ALL

Date : -
Investment : -
Value on selected date : -

Returns Calculator
SIP Calculator
VIP (Value Avg)

Amount

₹

Investment Date
Sell Date

Investment Value

-
Sell Value

-
Profit/Loss

-
Annualised Returns

-

Date : -
Investment : -
Value on selected date : -

Returns (NAV as on 22nd September, 2025)

Period Invested for	₹10000 Invested on	Latest Value	Absolute Returns	Annualised Returns	Category Avg	Rank within Category
1 Week	15-Sep-25	10022.90	0.23%	-	0.83%	195/226
1 Month	22-Aug-25	10018.30	0.18%	-	2.02%	205/225
3 Month	20-Jun-25	10539.20	5.39%	-	4.15%	78/216
6 Month	21-Mar-25	11038.80	10.39%	-	12.73%	146/212
YTD	01-Jan-25	10139.00	1.39%	-	4.51%	129/201
1 Year	20-Sep-24	10590.20	5.90%	5.87%	-0.37%	22/179
2 Year	22-Sep-23	17345.50	73.45%	31.65%	21.17%	6/139
3 Year	22-Sep-22	21922.90	119.23%	29.88%	20.47%	5/114
5 Year	22-Sep-20	26630.20	166.30%	21.63%	24.54%	59/90
Since Inception	13-Jul-18	43780.00	337.80%	22.76%	14.45%	28/199

Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 22nd September, 2025)

Period Invested for	₹1000 SIP Started on	Investments	Latest Value	Absolute Returns	Annualised Returns
1 Year	20-Sep-24	12000	12836.34	6.97 %	13.11 %
2 Year	22-Sep-23	24000	29897.61	24.57 %	22.65 %
3 Year	22-Sep-22	36000	54945.12	52.63 %	29.43 %
5 Year	22-Sep-20	60000	109170.27	81.95 %	24.15 %

SIP Calculator Detailed Returns Analysis

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 65.00% | Category average turnover ratio is 154.05%

Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)

Equity Holding : 95.88% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 95.88%

No of Stocks : 37 (Category Avg - 44.44) | Large Cap Investments : 40.3%| Mid Cap Investments : 16.51% | Small Cap Investments : 8.84% | Other : 30.22%

Top 10 Stocks in Portfolio

How to read this table?

Stock Invested in	Sector	Value(Mn)	% of Total Holdings	1M Change	1Y Highest Holding	1Y Lowest Holding	Quantity	1M Change in Qty
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals	7212.8	11.71%	0.02%	15.45% (Sep 2024)	11.69% (Jul 2025)	45.24 L	3.43 L
Dr. Reddys Laboratories Ltd.	Pharmaceuticals	5838.1	9.47%	0.62%	9.66% (May 2025)	8.28% (Jan 2025)	46.33 L	3.80 L
Divis Laboratories Ltd.	Pharmaceuticals	5689.6	9.23%	1.10%	9.23% (Aug 2025)	1.86% (Nov 2024)	9.28 L	1.75 L
Cipla Ltd.	Pharmaceuticals	4556.2	7.39%	-0.15%	9.71% (Jan 2025)	6.52% (Sep 2024)	28.67 L	-0.95 L
Aurobindo Pharma Ltd.	Pharmaceuticals	4021.9	6.53%	0.82%	7.05% (Apr 2025)	4.26% (Sep 2024)	39.13 L	8.56 L
Lupin Ltd.	Pharmaceuticals	3353.3	5.44%	0.33%	5.44% (Aug 2025)	3.79% (Jun 2025)	17.70 L	1.52 L
Alkem Laboratories Ltd.	Pharmaceuticals	2467	4.00%	0.17%	4.49% (Feb 2025)	1.63% (Oct 2024)	4.65 L	0.00
Mankind Pharma Ltd.	Pharmaceuticals	2157.6	3.50%	-0.37%	4.2% (Jun 2025)	0.62% (Nov 2024)	8.73 L	-0.49 L
Biocon Ltd.	Pharmaceuticals	1978.7	3.21%	-0.43%	5.02% (Jun 2025)	0% (Sep 2024)	56.80 L	0.00
Gland Pharma Ltd.	Pharmaceuticals	1772.8	2.88%	-0.33%	4.63% (Sep 2024)	2.88% (Aug 2025)	9.47 L	0.00

- indicates change in weight in the portfolio. # indicates a new entry.

Detailed Portfolio Analysis

Name	Type of Instrument	Weight (%)
TREPS	TREPS	3.63%
Net Receivables	Net Receivables	0.36%
Margin	Margin	0.14%

Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 29th August, 2025)

Standard Deviation
Standard Deviation value gives an idea about how volatile fund returns has been in the past 3 years. Lower value indicates more predictable performance. So if you are comparing 2 funds (lets say Fund A and Fund B) in the same category. If Fund A and Fund B has given 9% returns in last 3 years, but Fund A standard deviation value is lower than Fund B. So you can say that there is a higher chance that Fund A will continue giving similar returns in future also whereas Fund B returns may vary.

Low volatility

12.61vs14.28

Category Avg
Beta
Beta value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market. So if you are comparing 2 funds (lets say Fund A and Fund B) in the same category. If Fund A and Fund B has given 9% returns in last 3 years, but Fund A beta value is lower than Fund B. So you can say that there is a higher chance that Fund A will continue giving similar returns in future also whereas Fund B returns may vary.

High volatility

0.9vs0.86

Category Avg
Sharpe Ratio
Sharpe ratio indicates how much risk was taken to generate the returns. Higher the value means, fund has been able to give better returns for the amount of risk taken. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the standard deviation of returns. For example, if fund A and fund B both have 3-year returns of 15%, and fund A has a Sharpe ratio of 1.40 and fund B has a Sharpe ratio of 1.25, you can chooses fund A, as it has given higher risk-adjusted return.

Better risk adjusted returns

1.57vs0.84

Category Avg
Treynor's Ratio
Treynor's ratio indicates how much excess return was generated for each unit of risk taken. Higher the value means, fund has been able to give better returns for the amount of risk taken. It is calculated by subtracting the risk-free return, defined as an Indian Government Bond, from the fund's returns, and then dividing by the beta of returns. For example, if fund A and fund B both have 3-year returns of 15%, and fund A has a Treynor's ratio of 1.40 and fund B has a Treynor's ratio of 1.25, then you can chooses fund A, as it has given higher risk-adjusted return.

Better risk adjusted returns

0.22vs0.16

Category Avg
Jensen's Alpha
Alpha indicates how fund generated additional returns compared to a benchmark. Let's say if a fund A benchmarks its returns with Nifty50 returns then alpha equal to 1.0 indicates the fund has beaten the nifty returns by 1%, so the higher the alpha, the better.

Better risk adjusted returns

4.83vs3.93

Category Avg

Alternative Funds (Category Peers)

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth	NA	389.09	16.86	35.22	56.28	52.12	37.21
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth	NA	249.75	3.63	13.03	19.78	28.29	20.16
Nippon India US Equity Opportunities Fund - Direct Plan - Growth	NA	713.51	2.68	7.44	11.62	16.98	23.15
Franklin Asian Equity Fund - Direct - Growth	NA	259.99	6.02	12.45	16.92	16.71	14.53
Nippon India Japan Equity Fund - Direct Plan - Growth	NA	283.56	2.71	13.02	14.69	16.22	19.69
Motilal Oswal Business Cycle Fund - Direct Plan - Growth	NA	1976.19	1.78	6.50	14.47	14.96	0.00
HDFC Defence Fund - Direct Plan - Growth	NA	6532.01	5.43	-4.89	30.49	13.93	0.00
HDFC Transportation and Logistics Fund - Direct Plan - Growth	NA	1533.43	7.44	21.38	32.86	9.97	0.00
HDFC Pharma and Healthcare Fund - Direct Plan - Growth	NA	1909.30	-0.37	6.54	8.33	9.39	0.00
WhiteOak Capital Pharma and Healthcare Fund - Direct Plan - Growth	NA	423.51	-1.07	7.10	8.85	9.08	0.00

Detailed Comparison

More Funds from ICICI Prudential Mutual Fund

Out of 108 mutual fund schemes offered by this AMC, 4 is/are ranked 5 * , 6 is/are ranked 4 * , 13 is/are ranked 3 * , 4 is/are ranked 2 * , 4 is/are ranked 1 * , and 77 schemes are not ranked. See more about AMC

Scheme Name	Crisil Rank	Asset Size (Cr)	1M	3M	6M	1Y	3Y
ICICI Prudential Large Cap Fund - Direct Plan - Growth	5	71839.85	1.09	1.99	9.94	1.83	19.36
ICICI Prudential Balanced Advantage Fund - Direct Plan - Growth	NA	65710.61	1.32	2.90	9.69	7.10	14.04
ICICI Prudential Multi-Asset Fund - Direct Plan - Growth	4	64770.24	2.65	3.47	10.03	9.51	20.73
ICICI Prudential Value Fund - Direct Plan - Growth	4	53750.43	1.79	2.63	11.03	2.86	23.01
ICICI Prudential Liquid Fund - Direct Fund - Growth	1	49438.50	0.48	1.44	3.29	6.92	7.08
ICICI Prudential Equity & Debt Fund - Direct Plan - Growth	4	45151.97	1.68	3.57	10.20	5.63	20.65
ICICI Prudential Money Market Fund - Direct Plan - Growth	3	37886.78	0.47	1.56	4.07	7.93	7.64
ICICI Prudential Corporate Bond Fund - Direct Plan - Growth	2	33452.55	0.49	1.31	4.35	8.41	8.05
ICICI Prudential Equity - Arbitrage Fund - Direct Plan - Growth	3	32592.70	0.32	1.35	3.36	7.19	7.63
ICICI Prudential India Opportunities Fund - Direct Plan - Growth	NA	29871.10	1.60	1.99	10.25	2.42	24.38